Moderna shares rebound after six days of losses. Analysts mixed on stock with Strong Sell rating but potential for future growth.

Urge your representatives in Congress to support its programs to increase access to vaccines around the world.

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Immunocompromised people and those who are over 65 years of age or older should get a second dose of this year’s COVID-19 ...

The 2024-2025 COVID-19 vaccines are available, and the CDC recommends that adults over 65 and immunocompromised people get ...

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

Dolly Parton embodies "the true meaning of inclusion, togetherness, understanding and being in service to people," says the ...

Galleries and museums are displaying works that depict climate change and its brutality for ecosystems. For the artists, they ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

The science behind vaccines is based on the fundamental principle of training the immune system to recognize and fight ...

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 23, 2024. REUTERS/Brendan McDermid/File Photo The Nasdaq ended higher on Friday, driven by megacap ...

The United Nations sexual and reproductive health agency UNFPA, has reported that Ukraine is in urgent need of "comprehensive recovery strategies focused on human capital and socioeconomic reform." ...